All Type of News
Three drug makers seek bigger market share
Three pharmaceutical firms SK Chemical, Pacific Pharm and Jeil Pharm are gearing up to boost its marketing activities in the domestic cataplaster market showing a sluggish trend, apparently perturbed by growing numb...
KPA to keep out other attempts to sell OTC drugs.
Recently medical communities and civic groups have strongly demanded for the OTC drugs to be available at general stores or supermarkets, thus threatening the pharmacy professions.
To cope with such challenges, the...
Government drafts plans for FTA-damaged pharmaceutical sectorFollowing the clinching of a free trade agreement with the United States last month, the government will finalize its plan to support the domestic research and development (R&D)...
|
2007 GARD general meeting in Seoul
The second general meeting of The Global Alliance against Chronic Respiratory Diseases (GARD), part of the World Health Organization's global work to prevent and control chronic diseases, will be hosted by the Korean ...
Delayed generic introduction under patent application to cause 400 BW of loss.
It is estimated that the delayed market launching of generic drugs caused by the new patent related registration process under the KORUS FTA may generate about 396,800 million won of sales losses for 5 years in th...
Leading drug makers bite bigger share in ethical market
Major pharmaceutical firms, including Daewoong Pharm and Hanmi Pharm, increased their share of the pie in the domestic ethical market, according to a report released by Woori Investment and Secruities on May 17.
Th...
Wholesaler margin thinner
Domestic drug wholesalers have seen their profit margins worsening for the past few years as domestic and foreign drug markers' continuous margin cut negatively affected their bottom lines, according to pharmaceutical...
Court accepted Ahngook's interim injunction for Lebotension sales.
Ahngook earlier filed an interim injunction to the court against the lawsuit for the sales suspension of "Lebotension". Now, the court accepted the injunction.
On Feb. 28 this year Pfizer filed an interim injuncti...
Allergan Korea faces damage suit
Hanall Pharm said on May 16 it has decided to seek 2.0 billion won in compensation from Allergan Korea for its defamed company image.
Hanall has marketed BTXA, which is in a direct competition with Allergan Korea's...
KFDA approves new anticancer drugThe Korea Food and Drug Administration approved a home-grown anticancer medicine CreaVax-RCC developed by Creagene Inc., a local bio-venture company, for sale in the domestic ma...
|
